2025年11月30日,中国関連株の7株は,継続的なリスクにもかかわらず,取引活動により,増加しました. Seven Chinese-linked stocks surged in volume on Nov. 30, 2025, due to trading activity, despite ongoing risks.

市場報道によると,2025年11月30日,中国株のUP Fintech,Baiya International,Regencell Bioscience,RBB Bancorp,China SXT Pharmaceuticals,HF Foods,Diageoの取引量が急増した. Seven Chinese stocks—UP Fintech, Baiya International, Regencell Bioscience, RBB Bancorp, China SXT Pharmaceuticals, HF Foods, and Diageo—spiked in trading volume on November 30, 2025, according to MarketBeat. 企業は,中国における業務又はアジア米のコミュニティに奉仕して,ヒジテク,バイオテクノロジー,銀行,医薬品,食品の流通を図る. The companies span fintech, biotech, banking, pharmaceuticals, and food distribution, with operations in China or serving Asian-American communities. ADRS又はGDRSにより中国経済に露出させるが,規制,行政,通貨交代,地道化などからリスクを負う. Listed via ADRs or GDRs, they offer exposure to China’s economy but carry risks from regulation, governance, currency shifts, and geopolitics.